Regent Pacific Group Limited (HKG:0575)

Market Cap	230.72M
Revenue (ttm)	5.58M
Net Income (ttm)	-34.81M
Shares Out	228.44M
EPS (ttm)	-0.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,100
Average Volume	60,444
Open	1.020
Previous Close	1.010
Day's Range	1.020 - 1.020
52-Week Range	0.320 - 1.240
Beta	1.06
RSI	49.59
Earnings Date	Aug 26, 2025

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0575

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.

Financial numbers in USD